MYGN
Myriad Genetics Inc
4.10$
+3.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1995 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 63.6% | 63.9% | 47.0% | 25.6% | 80.8% | 79.7% | 54.2% | 56.2% | 72.8% | 85.3% | 91.2% | 67.2% | 75.6% | 78.5% | 79.8% | 68.5% | 61.2% | 60.2% | 39.1% | 37.0% | 35.7% | 25.0% | 27.9% | 22.3% | 27.4% | 36.7% | 22.9% | 27.4% | 29.0% | 47.1% | |
| 16.6% | 20.6% | 21.7% | 10.1% | 52.8% | 20.9% | 38.8% | 33.7% | 44.6% | 31.1% | 35.6% | 38.2% | 47.6% | 13.6% | 15.6% | 8.6% | 12.5% | 12.9% | 7.9% | 8.4% | 7.8% | 8.5% | 9.4% | 6.0% | 8.2% | 19.5% | 4.7% | 11.5% | 10.0% | 21.2% | |
| 16.6% | 20.6% | 21.7% | 18.5% | 75.7% | 73.9% | 46.4% | 39.8% | 61.2% | 71.6% | 82.3% | 57.0% | 65.8% | 67.9% | 67.9% | 56.7% | 49.3% | 46.3% | 22.6% | 18.9% | 18.1% | 12.5% | 15.4% | 8.8% | 10.6% | 25.7% | 9.6% | 12.3% | 10.0% | 21.2% | |
| – | 0.7% | 0.9% | 6.0% | 2.6% | 3.3% | 4.7% | 12.2% | 7.7% | 11.6% | 8.0% | 8.6% | 9.1% | 9.6% | 8.1% | 8.3% | 9.1% | 12.1% | 10.3% | 11.4% | 10.8% | 7.9% | 8.8% | 8.9% | 6.3% | 6.9% | 8.5% | 10.0% | 11.8% | 16.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -67.2% | 1.3% | 1.7% | 0.6% | 2.9% | 3.3% | 4.3% | 3.5% | 2.9% | 2.0% | 1.9% | 1.2% | 1.7% | 1.9% | 2.7% | 4.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 9.2% | 8.2% | 7.1% | 20.5% | 23.1% | 22.2% | 26.1% | 27.1% | 26.7% | 23.2% | 18.1% | 23.9% | 25.1% | 27.9% | 7.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.3% | 2.7% | 2.3% | 1.7% | 24.9% | 25.1% | 25.8% | 40.7% | 38.7% | 43.8% | 40.8% | 30.6% | 31.7% | 30.5% | 25.5% | 21.7% | |
| 11.8% | 13.0% | 14.7% | 10.1% | 27.0% | 18.9% | 18.1% | 10.6% | 8.0% | 14.6% | 9.7% | 9.4% | 14.8% | 6.9% | 6.1% | 7.2% | 8.0% | 9.4% | 12.7% | 13.6% | 15.0% | 36.5% | 17.8% | 30.3% | 37.9% | 26.7% | 26.1% | 31.7% | 31.8% | 47.9% | |
| 11.3% | 12.9% | 14.7% | 9.9% | 27.0% | 18.9% | 18.1% | 10.6% | 8.0% | 14.6% | 9.7% | 9.4% | 14.8% | 6.9% | 4.6% | 5.6% | 6.5% | 8.0% | 9.8% | 9.0% | 8.2% | 18.0% | 8.7% | 7.5% | 10.3% | 15.5% | 11.4% | 13.6% | 16.0% | 18.9% | |
| 0.4% | 0.4% | 0.1% | – | – | – | 2.3% | – | – | – | – | – | – | – | – | 1.6% | – | – | – | – | – | 5.4% | 5.8% | 5.0% | 1.0% | 1.0% | 1.2% | 1.4% | 1.2% | 1.0% | |
| 2.8% | 3.4% | 7.6% | 5.4% | 4.0% | 5.6% | 6.0% | 6.3% | 4.2% | 7.5% | 4.3% | 4.2% | 5.0% | 3.0% | 1.5% | 1.9% | 1.5% | 2.3% | 2.8% | 2.8% | 2.4% | 1.8% | 2.2% | 2.1% | 1.4% | 2.2% | 2.4% | 2.3% | 3.1% | 4.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 14.4% | – | – | – | 3.4% | 3.9% | 17.0% | |
| 88.2% | 87.0% | 85.3% | 89.9% | 73.0% | 81.1% | 81.9% | 89.4% | 92.0% | 85.4% | 90.3% | 90.6% | 85.2% | 93.1% | 93.9% | 92.8% | 92.0% | 90.6% | 87.3% | 86.4% | 85.0% | 63.6% | 82.2% | 69.7% | 62.1% | 73.3% | 73.9% | 68.3% | 68.2% | 52.1% | |
| -18.7% | -31.7% | -50.3% | -81.9% | -49.5% | -34.8% | -46.9% | -54.0% | -73.9% | -112.8% | -78.6% | -67.2% | -41.0% | -25.7% | -1.8% | -6.3% | -1.8% | 3.8% | 0.2% | -10.0% | -8.3% | -6.5% | 4.6% | 1.6% | -16.0% | -19.2% | -30.5% | -54.9% | -73.6% | -158.9% | |
| 38.0% | 46.8% | 55.2% | 70.1% | 38.0% | 26.5% | 30.1% | 28.1% | 29.0% | 38.7% | 26.2% | 21.9% | 18.7% | 21.1% | 16.7% | 15.0% | 12.5% | 10.4% | 9.5% | 9.7% | 8.3% | 5.7% | 6.1% | 4.9% | 5.3% | 5.9% | 6.7% | 7.2% | 8.8% | 13.2% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.